These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Islet cell and other organ-specific autoantibodies in Chinese children with insulin-dependent diabetes mellitus. Tsai WY; Riley WJ; Lee JS; Tsai WS J Formos Med Assoc; 1990 Nov; 89(11):969-71. PubMed ID: 1982128 [TBL] [Abstract][Full Text] [Related]
24. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry. Gorus FK; Sodoyez JC; Pipeleers DG; Keymeulen B; Foriers A; Van Schravendijk CF Diabetologia; 1992 Nov; 35(11):1080-6. PubMed ID: 1473619 [TBL] [Abstract][Full Text] [Related]
25. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors. Hehmke B; Schröder D; Klöting I; Kohnert KD J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761 [TBL] [Abstract][Full Text] [Related]
26. Studies of autoantibodies reactive with thyroid membrane antigens and insulin in non obese diabetic mice. Bernard NF; Ertug F; Margolese H Autoimmunity; 1992; 13(2):159-64. PubMed ID: 1467437 [TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells. Ejiri K; Taniguchi H; Morimoto Y; Yamashiro Y; Baba S; Srikanta S; Eisenbarth GS Diabetes Res Clin Pract; 1990 Apr; 9(1):1-5. PubMed ID: 2161728 [TBL] [Abstract][Full Text] [Related]
28. Autoantibodies present at onset of type I diabetes recognize multiple islet cell antigens. Karounos DG; Nell LJ; Thomas JW Autoimmunity; 1990; 6(1-2):79-91. PubMed ID: 2129772 [TBL] [Abstract][Full Text] [Related]
29. Complement-mediated cytotoxic effects of islet cell surface antibodies in non-diabetic subjects with antecedent mumps infection and diabetic risk. Ratzmann KP; Jahr H; Richter KV Exp Clin Endocrinol; 1988 May; 91(2):176-82. PubMed ID: 3044806 [TBL] [Abstract][Full Text] [Related]
30. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study. Ziegler B; Klöting I; Besch W; Ziegler M; Hahn HJ Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954 [TBL] [Abstract][Full Text] [Related]
31. Pancreatic islet cells in tissue culture: function and immunoreactivity with serum autoantibodies from diabetes type-1 patients and monoclonal antibodies ICA-1. Zlobina EN; Rossels AN; Yesenin VI; Demin YM; Bachurin PS; Filatov AV; Brikova SV Exp Clin Endocrinol; 1989 May; 93(2-3):161-5. PubMed ID: 2673809 [TBL] [Abstract][Full Text] [Related]
32. Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata. Noso S; Park C; Babaya N; Hiromine Y; Harada T; Ito H; Taketomo Y; Kanto K; Oiso N; Kawada A; Suzuki T; Kawabata Y; Ikegami H J Clin Endocrinol Metab; 2015 May; 100(5):1976-83. PubMed ID: 25734250 [TBL] [Abstract][Full Text] [Related]
33. Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody? Okada S; Sato K; Ichiki K; Tanokuchi S; Ishii K; Ota Z; Takeda A J Int Med Res; 1991; 19(3):234-6. PubMed ID: 1936512 [TBL] [Abstract][Full Text] [Related]
34. Graves' disease of the beta cell: glucose dysregulation due to islet-cell stimulating antibodies. Wilkin TJ; Hammonds P; Mirza I; Bone AJ; Webster K Lancet; 1988 Nov; 2(8621):1155-8. PubMed ID: 2903375 [TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232 [TBL] [Abstract][Full Text] [Related]
36. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289 [TBL] [Abstract][Full Text] [Related]
37. Effect of syngeneic islet antigen administration on complement-dependent antibody-mediated cytotoxicity to islet cells and diabetes onset in diabetes-prone BB/OK rats. Schröder D; Schmidt S; Klöting I; Hehmke B Autoimmunity; 1993; 14(4):283-9. PubMed ID: 8347771 [TBL] [Abstract][Full Text] [Related]
38. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Petersen JS; Marshall MO; Baekkeskov S; Hejnaes KR; Høier-Madsen M; Dyrberg T Diabetologia; 1993 Jun; 36(6):510-5. PubMed ID: 8335172 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens. Houssaint E; Pogu S; Ouary M; Sai P Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582 [TBL] [Abstract][Full Text] [Related]
40. Novel islet, duct, and acinar cell markers defined by monoclonal autoantibodies from prediabetic BB rats. Contreas G; Jørgensen J; Madsen OD Pancreas; 1990 Sep; 5(5):540-7. PubMed ID: 2122446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]